News: Press Release

Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal

Proprietary technology demonstrates significant improvement in short-term and long-term outcomes. ATLANTA – July 10, 2017 – AMNIOX Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in… read more

Amniox Medical Enters into Agreement with Intalere

ATLANTA, GA – June 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane… read more

New Clinical Evidence Continues to Support the Effectiveness and Value of AMNIOX Medical Product

Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound… read more

Bio-Tissue Announces Global Online Purchase Availability for Cliradex Light & Website Relaunch

  Bio-Tissue, a business unit  of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, www.cliradex.com. International purchases may be directed to Amazon Marketplace. Cliradex Light… read more

Bio-Tissue® Research Further Demonstrates Effectiveness of Cryopreserved Amniotic Membrane for Ocular Surface Healing

  LOS ANGELES, May 2, 2017 – Bio-Tissue, Inc., a business unit of TissueTech™, Inc., announces the presentation of key research at this week’s American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, May 5-9, further demonstrating the clinical… read more

AMNIOX Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines

Expanded Access to Industry-Leading Technology for 10.2 Million Military Personnel ATLANTA, GA – April 17, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its NEOX and CLARIX product lines. The agreement… read more

AMNIOX Highlights Three Studies Demonstrating Effectiveness of Umbilical Cord Tissue for Treating Chronic Wounds

Studies Document Healing Rates of 78% – 87% ATLANTA, GA – April 7, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the publication of three studies concerning NEOX CORD 1K, its cryopreserved human umbilical cord tissue. In contrast… read more

AMNIOX Study Confirms Benefits of CLARIX FLO for Plantar Fasciitis

Study Demonstrates Decreased Pain and Improved Functional Recovery ATLANTA, GA – March 30, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today the results of a study demonstrating the application of its unique cryopreserved human umbilical cord tissue… read more

AMNIOX Highlights Study Demonstrating Improved Outcomes in Patients Treated with CLARIX® Regenerative Matrix as an Adjunct to Lumbar Discectomy

ATLANTA – October 26, 2016—AMNIOX Medical, Inc., a TissueTech™, Inc., company, announced the results of a prospective randomized clinical study of its proprietary cryopreserved Amniotic Membrane (AM) as an adjunct to lumbar discectomy. The findings will be presented at the… read more

Bio-Tissue® Announces Strategic Collaboration Agreement with SightLife™ to Provide Cryopreserved Amniotic Membrane Products to Kaiser Permanente Facilities

MIAMI, Fla., August 30, 2016 – Bio-Tissue, Inc., the industry leader in regenerative tissue therapies and ocular hygiene products for lid margin and ocular surface diseases, is pleased to announce a strategic collaboration agreement with SightLife, a Seattle-based eye bank… read more